Jounce Therapeutics, Inc. develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial. It is also developing JTX-8064, an antibody that binds to leukocyte immunoglobulin like receptor B2.
Market Cap | 98.024 Million | Shares Outstanding | 52.14 Million | Avg 30-day Volume | 1.538 Million |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.99 |
Price to Revenue | 0.6995 | Debt to Equity | 0.0 | EBITDA | -47.794 Million |
Price to Book Value | 0.3133 | Operating Margin | -63.70980000000001 | Enterprise Value | -132.182 Million |
Current Ratio | 8.369 | EPS Growth | 0.456 | Quick Ratio | 8.042 |
1 Yr BETA | 0.728 | 52-week High/Low | 5.87 / 0.58 | Profit Margin | -62.0963 |
Operating Cash Flow Growth | 65.4143 | Altman Z-Score | -0.1816 | Free Cash Flow to Firm | -26.557 Million |
Please sign in first
none
39.2 Thousand total shares from 1 transactions
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
10,000 | 2023-05-03 | 3 | |
|
1 | 2023-05-03 | 3 | |
|
0 | 2023-05-03 | 2 | |
DRAPKIN KIMBERLEE C PRESIDENT, CFO AND TREASURER |
|
0 | 2023-05-03 | 2 |
|
0 | 2023-05-03 | 2 | |
|
0 | 2023-05-03 | 2 | |
|
0 | 2023-05-03 | 2 | |
|
0 | 2023-05-03 | 2 | |
|
0 | 2023-05-03 | 2 | |
|
0 | 2023-05-03 | 2 | |
|
10,000 | 2023-05-03 | 2 | |
|
36,367,727 | 2023-05-03 | 2 | |
COLE HUGH M CHIEF OPERATING OFFICER |
|
110,082 | 2023-01-09 | 2 |
TREHU ELIZABETH CHIEF MEDICAL OFFICER |
|
103,417 | 2023-01-09 | 1 |
|
20,000 | 2022-06-24 | 1 | |
|
4,698,661 | 2021-11-12 | 0 | |
|
50,468 | 2021-11-12 | 0 | |
|
6,598,661 | 2021-09-15 | 0 | |
|
5,539,727 | 2020-10-16 | 0 | |
|
0 | 2020-06-26 | 0 | |
|
3,456,463 | 2017-02-01 | 0 | |
THIRD ROCK VENTURES GP II, L.P. |
|
3,048,780 | 2017-02-01 | 0 |
|
No longer subject to file | 2017-02-01 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-05-04 07:44:21 -0400 | 2023-05-03 | D | 15,700 | d | 0 | direct | ||||||||||
2023-05-04 07:44:53 -0400 | 2023-05-03 | D | 175,000 | d | 0 | direct | ||||||||||
2023-05-04 07:44:53 -0400 | 2023-05-03 | D | 182,926 | d | 0 | direct | ||||||||||
2023-05-04 07:44:53 -0400 | 2023-05-03 | U | 188,778 | d | 1 | direct | ||||||||||
2023-05-04 07:44:53 -0400 | 2023-05-03 | D | 200,000 | d | 0 | direct | ||||||||||
2023-05-04 07:44:53 -0400 | 2023-05-03 | D | 665,169 | d | 0 | direct | ||||||||||
2023-05-04 07:44:37 -0400 | 2023-05-03 | U | 5,000 | d | 0 | direct | ||||||||||
2023-05-04 07:44:37 -0400 | 2023-05-03 | D | 13,350 | d | 0 | direct | ||||||||||
2023-05-04 07:44:37 -0400 | 2023-05-03 | D | 15,700 | d | 0 | direct | ||||||||||
2023-05-04 07:44:37 -0400 | 2023-05-03 | D | 15,700 | d | 0 | direct | ||||||||||
2023-05-04 07:44:37 -0400 | 2023-05-03 | D | 15,700 | d | 0 | direct | ||||||||||
2023-05-04 07:44:37 -0400 | 2023-05-03 | D | 16,260 | d | 0 | direct | ||||||||||
2023-05-04 07:44:37 -0400 | 2023-05-03 | D | 20,000 | d | 0 | direct | ||||||||||
2023-05-04 07:44:37 -0400 | 2023-05-03 | D | 75,880 | d | 0 | direct | ||||||||||
2023-05-04 07:44:21 -0400 | 2023-05-03 | D | 10,840 | d | 0 | direct | ||||||||||
2023-05-04 07:44:21 -0400 | 2023-05-03 | D | 13,550 | d | 0 | direct | ||||||||||
2023-05-04 07:44:53 -0400 | 2023-05-03 | D | 165,954 | d | 0 | direct | ||||||||||
2023-05-04 07:44:21 -0400 | 2023-05-03 | D | 15,700 | d | 0 | direct | ||||||||||
2023-05-04 07:44:21 -0400 | 2023-05-03 | D | 15,700 | d | 0 | direct | ||||||||||
2023-05-04 07:44:21 -0400 | 2023-05-03 | D | 20,000 | d | 0 | direct | ||||||||||
KAMEN ROBERT - Director see footnote |
2023-05-04 07:44:21 -0400 | 2023-05-03 | U | 33,875 | d | 0 | indirect | |||||||||
2023-05-04 07:44:21 -0400 | 2023-05-03 | U | 60,975 | d | 0 | direct | ||||||||||
2023-05-04 07:43:59 -0400 | 2023-05-03 | D | 7,850 | d | 0 | direct | ||||||||||
2023-05-04 07:43:59 -0400 | 2023-05-03 | D | 15,700 | d | 0 | direct | ||||||||||
2023-05-04 07:43:59 -0400 | 2023-05-03 | D | 20,000 | d | 0 | direct | ||||||||||
2023-05-04 07:43:59 -0400 | 2023-05-03 | D | 31,400 | d | 0 | direct | ||||||||||
2023-05-04 07:45:31 -0400 | 2023-05-03 | D | 7,850 | d | 0 | direct | ||||||||||
2023-05-04 07:45:31 -0400 | 2023-05-03 | D | 20,000 | d | 0 | direct | ||||||||||
2023-05-04 07:45:31 -0400 | 2023-05-03 | D | 31,400 | d | 0 | direct | ||||||||||
2023-05-05 16:38:21 -0400 | 2023-05-03 | J | 10,000 | $9,737.70 | a | 10,000 | direct | |||||||||
TANG KEVIN C - Director - > 10% Owner by lp |
2023-05-05 16:37:26 -0400 | 2023-05-03 | J | 10,000 | $9,737.70 | a | 10,000 | indirect | ||||||||
TANG KEVIN C - Director - > 10% Owner by lp |
2023-05-05 16:37:26 -0400 | 2023-05-03 | U | 5,300,087 | $1.85 | d | 0 | indirect | ||||||||
2023-05-04 07:43:24 -0400 | 2023-05-03 | D | 97,500 | d | 0 | direct | ||||||||||
2023-05-04 07:43:41 -0400 | 2023-05-03 | D | 10,840 | d | 0 | direct | ||||||||||
2023-05-04 07:43:41 -0400 | 2023-05-03 | D | 13,550 | d | 0 | direct | ||||||||||
2023-05-04 07:43:41 -0400 | 2023-05-03 | D | 15,700 | d | 0 | direct | ||||||||||
2023-05-04 07:43:41 -0400 | 2023-05-03 | D | 15,700 | d | 0 | direct | ||||||||||
2023-05-04 07:43:41 -0400 | 2023-05-03 | D | 15,700 | d | 0 | direct | ||||||||||
2023-05-04 07:43:41 -0400 | 2023-05-03 | D | 20,000 | d | 0 | direct | ||||||||||
2023-05-04 07:43:41 -0400 | 2023-05-03 | D | 34,271 | d | 0 | direct | ||||||||||
2023-05-04 07:43:24 -0400 | 2023-05-03 | D | 8,130 | d | 0 | direct | ||||||||||
2023-05-04 07:43:24 -0400 | 2023-05-03 | U | 25,751 | d | 40,267 | direct | ||||||||||
2023-05-04 07:43:24 -0400 | 2023-05-03 | U | 40,267 | d | 0 | direct | ||||||||||
2023-05-04 07:43:24 -0400 | 2023-05-03 | D | 44,500 | d | 0 | direct | ||||||||||
2023-05-04 07:43:24 -0400 | 2023-05-03 | D | 44,500 | d | 0 | direct | ||||||||||
2023-05-04 07:43:24 -0400 | 2023-05-03 | D | 53,400 | d | 0 | direct | ||||||||||
2023-05-04 07:43:24 -0400 | 2023-05-03 | D | 55,000 | d | 0 | direct | ||||||||||
2023-05-04 07:43:24 -0400 | 2023-05-03 | D | 77,235 | d | 0 | direct | ||||||||||
2023-05-04 07:43:24 -0400 | 2023-05-03 | D | 206,005 | d | 0 | direct | ||||||||||
2023-05-04 07:43:08 -0400 | 2023-05-03 | D | 10,163 | d | 0 | direct | ||||||||||
2023-05-04 07:43:08 -0400 | 2023-05-03 | D | 15,700 | d | 0 | direct | ||||||||||
2023-05-04 07:43:08 -0400 | 2023-05-03 | D | 15,700 | d | 0 | direct | ||||||||||
2023-05-04 07:43:08 -0400 | 2023-05-03 | D | 15,700 | d | 0 | direct | ||||||||||
2023-05-04 07:43:08 -0400 | 2023-05-03 | D | 20,000 | d | 0 | direct | ||||||||||
2023-05-04 07:43:08 -0400 | 2023-05-03 | D | 27,100 | d | 0 | direct | ||||||||||
2023-05-04 07:45:13 -0400 | 2023-05-03 | D | 20,000 | d | 0 | direct | ||||||||||
2023-05-04 07:45:13 -0400 | 2023-05-03 | D | 31,400 | d | 0 | direct | ||||||||||
2023-05-04 07:44:53 -0400 | 2023-05-03 | D | 15,000 | d | 0 | direct | ||||||||||
2023-05-04 07:44:53 -0400 | 2023-05-03 | D | 54,200 | d | 0 | direct | ||||||||||
2023-05-04 07:44:53 -0400 | 2023-05-03 | D | 125,010 | d | 0 | direct | ||||||||||
2023-05-04 07:44:53 -0400 | 2023-05-03 | D | 150,000 | d | 0 | direct | ||||||||||
2023-05-04 07:44:53 -0400 | 2023-05-03 | D | 150,010 | d | 0 | direct | ||||||||||
2023-04-06 16:37:50 -0400 | 2023-04-04 | S | 39,228 | $1.85 | d | 188,779 | direct | yes | 0.0 | 2.6738 | 2.6738 | 4 | 0.0 | 1 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
JOUNCE THERAPEUTICS INC JNCE | 2023-05-04 22:15:04 UTC | 3.4156 | 1.4044 | 15000 |
JOUNCE THERAPEUTICS INC JNCE | 2023-05-04 21:45:04 UTC | 3.4156 | 1.4044 | 15000 |
JOUNCE THERAPEUTICS INC JNCE | 2023-05-04 21:15:04 UTC | 3.4156 | 1.4044 | 15000 |
JOUNCE THERAPEUTICS INC JNCE | 2023-05-04 20:45:04 UTC | 3.4156 | 1.4044 | 15000 |
JOUNCE THERAPEUTICS INC JNCE | 2023-05-04 20:15:04 UTC | 3.4156 | 1.4044 | 15000 |
JOUNCE THERAPEUTICS INC JNCE | 2023-05-04 19:45:04 UTC | 3.4156 | 1.4044 | 15000 |
JOUNCE THERAPEUTICS INC JNCE | 2023-05-04 19:15:04 UTC | 3.4156 | 1.4044 | 15000 |
JOUNCE THERAPEUTICS INC JNCE | 2023-05-04 18:45:03 UTC | 3.4156 | 1.4044 | 15000 |
JOUNCE THERAPEUTICS INC JNCE | 2023-05-04 18:15:04 UTC | 3.4156 | 1.4044 | 15000 |
JOUNCE THERAPEUTICS INC JNCE | 2023-05-04 17:45:03 UTC | 3.4156 | 1.4044 | 15000 |
JOUNCE THERAPEUTICS INC JNCE | 2023-05-04 17:15:04 UTC | 3.4156 | 1.4044 | 15000 |
JOUNCE THERAPEUTICS INC JNCE | 2023-05-04 16:45:04 UTC | 3.3042 | 1.5158 | 15000 |
JOUNCE THERAPEUTICS INC JNCE | 2023-05-04 16:15:04 UTC | 3.3042 | 1.5158 | 15000 |
JOUNCE THERAPEUTICS INC JNCE | 2023-05-04 15:45:04 UTC | 3.3042 | 1.5158 | 15000 |
JOUNCE THERAPEUTICS INC JNCE | 2023-05-04 15:15:03 UTC | 3.3042 | 1.5158 | 15000 |
JOUNCE THERAPEUTICS INC JNCE | 2023-05-04 14:45:03 UTC | 3.3042 | 1.5158 | 10000 |
JOUNCE THERAPEUTICS INC JNCE | 2023-05-04 14:15:04 UTC | 3.3042 | 1.5158 | 10000 |
JOUNCE THERAPEUTICS INC JNCE | 2023-05-04 13:45:04 UTC | 2.9642 | 1.8558 | 10000 |
JOUNCE THERAPEUTICS INC JNCE | 2023-05-04 13:15:04 UTC | 2.9642 | 1.8558 | 10000 |
JOUNCE THERAPEUTICS INC JNCE | 2023-05-04 12:45:04 UTC | 2.9642 | 1.8558 | 10000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|